DBAY Advisors to buy Alliance Pharma in £349.7m deal
AIM-listed Alliance Pharma said on Friday that it has agreed to be bought by asset management firm DBAY Advisors in a £349.7m deal.
10 Jan 07:56 · ShareCast
Alliance Pharma to accept £349.7m buyout offer from biggest investor
The deal would see the Aim-listed pharma firm leave the public markets, after several tumultuous years including a fine from the competition watchdog.
10 Jan 10:14 · LBC
last updated on 10 Jan 13:18